MedTrace Logo

3-year Follow-up of Patients Treated With Jetstream Combined With Ranger for Calcified Femoropopliteal Lesions

NCT06173960 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-03-13

Study results available
· View outcomes & findings →

Summary

The goal of this non interventional study is to evaluate the long-term clinical effects (3-year follow-up after the procedure) of Jetstream atherectomy combined with a paclitaxel-eluting balloon (Ranger) in all patients who were treated for calcified femoropopliteal lesions (de novo, single or multiple, mono- or bilateral) between December 1, 2016 and December 31, 2020 at the Clinique Rhône-Durance, Avignon, France

Conditions

Interventions

DEVICE

atherectomy

Jetstream atherectomy in combination with Ranger paclitaxel elution balloon (Drug Coated Balloon (DCB))

Sponsors & Collaborators

  • Association de Provence pour la Promotion de l'Enseignement et la Recherche Cardiologique

    lead OTHER

Principal Investigators

  • Jérôme BRUNET, Dr · Clinique Rhône-Durance

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-03
Primary Completion
2023-11-03
Completion
2024-01-29

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06173960 on ClinicalTrials.gov